Search Results - "Farkić, Mihajlo"

Current status and future perspectives of fractional flow reserve derived from invasive coronary angiography by Dobrić, Milan, Furtula, Matija, Tešić, Milorad, Timčić, Stefan, Borzanović, Dušan, Lazarević, Nikola, Lipovac, Mirko, Farkić, Mihajlo, Ilić, Ivan, Boljević, Darko, Rakočević, Jelena, Aleksandrić, Srđan, Juričić, Stefan, Ostojić, Miodrag, Bojić, Milovan

“…Assessment of the functional significance of coronary artery stenosis using invasive measurement of fractional flow reserve (FFR) or non-hyperemic indices has…”
Get full text

Transcatheter Aortic Valve Implantation: A Report on Serbia's First Systematic Program by Boljevic, Darko, Bojic, Milovan, Farkic, Mihajlo, Sagic, Dragan, Topic, Dragan, Kovacevic, Vladimir, Lakcevic, Jovana, Veljkovic, Stefan, Dobric, Milan, Hinic, Sasa, Ilijevski, Nenad, Nikolic, Marko, Kaludjerovic, Aleksandra, Bunc, Matjaz, Nikolic, Aleksandra

“…Severe aortic stenosis, a highly-common valve disease in the elderly, has a poor prognosis if left untreated. To address the concern of effective procedures…”
Get full text

Transcatheter closure of atrial septal defect in a patient with Noonan syndrome after corrective surgery by Mangovski, Ljupćo, Farkić, Mihajlo, Jovović, Ljicjana

“…Transcatheter atrial septal defect (ASD) closure is considered to be a gold standard for patients with the suitable anatomy as compared to cardiac surgery…”
Get full text

Challenges in treatment of postinfarction ventricular septal defect and heart failure by Mangovski, Ljupčo, Kozlik-Feldmann, Rainer, Perić, Miodrag, Jovović, Ljiljana, Farkić, Mihajlo, Dekić, Dragica

“…Acquired ventricular septal defect (VSD) is uncommon, but serious mechanical complication of acute myocardial infarction with poor outcome and high mortality…”
Get full text

MiR-146a gene variant rs2910164 might be associated with coronary in-stent restenosis risk: Results from a pilot study and meta-analysis by Mihajlovic, Milica, Savic-Veselinovic, Marija, Farkic, Mihajlo, Zeljic, Katarina

“…Coronary in-stent restenosis (ISR) is an adverse effect that occurs in 20-35% of patients who have undergone percutaneous coronary intervention (PCI) with…”
Get full text